We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · December 08, 2021

Efficacy of Rituximab in Patients With Polymyalgia Rheumatica

The Lancet. Rheumatology


Additional Info

The Lancet. Rheumatology
Efficacy of rituximab in patients with polymyalgia rheumatica: a double-blind, randomised, placebo-controlled, proof-of-concept trial
Lancet Rheumatol 2021 Nov 01;3(11)E758-E766, DE Marsman, N denBroeder, FHJ vandenHoogen, AA denBroeder, A vanderMaas

Further Reading